Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-center Phase I Open-label Study of the Tolerability and Efficacy of Low-dose Ketamine Infusion for Treatment of Levodopa-Induced Dyskinesia in Patients With Parkinson's Disease

NCT06021756 is registered in ClinicalTrials.gov with University of Arizona as lead sponsor.

NCT NCT06021756
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06021756 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-center Phase I Open-label Study of the Tolerability and Efficacy of Low-dose Ketamine Infusion for Treatment of Levodopa-Induced Dyskinesia in Patients With Parkinson's Disease
Lead sponsor
University of Arizona
Phase
Phase 1
Overall status
Unknown status
Start date
July 28, 2019
Completion date
August 25, 2023
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

levodopa-induced dyskinesia, parkinson's disease